Local gene therapy for cystic fibrosis has begun testing in Europe.
Clinical trials of inhaled gene therapy for cystic fibrosis have launched in European countries, according to a press release from Imperial College London. The experimental drug, BI 3720931, developed by Boehringer Ingelheim, is a working version…